Kevin Koch insider trades

Open-market stock purchases and sales by Kevin Koch, President and CEO at Edgewise Therapeutics, Inc, from SEC Form 4 filings since Mar 31, 2010.

Recent trades

DateStockTradeValue
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$383K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$361K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$40.5K
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—

Companies traded

  • EWTX Edgewise Therapeutics, Inc: 10 sales, last Aug 12, 2026
  • MGEN Miragen Therapeutics, Inc: other filings, last May 21, 2020
  • ARRY Array Biopharma Inc: other filings, last Jul 24, 2013

Get free alerts when Kevin Koch files a new trade →